Both candidates made healthcare a central theme: Rudolph emphasized outreach to enroll children in CHIP and urged stable funding for early childhood education; Murphy highlighted a patient bill of rights and pressed for drug importation and disclosure of pharmaceutical spending.

Breaking: Only 49% of Americans are "Cost Secure"—able to consistently afford healthcare and medications—according to new West He… #Costsecurity #Healthpolicy #Healthcareaffordability #Prescriptiondrugcosts #UnitedStateshealthcare

Committee supports bills aimed at addressing prescription drug affordability and long-term care insurance.

Payer Matrix collaborates with Prime Therapeutics to source drugs at lower prices for members.

Representative Dieter testified in favor of Substitute House Bill 229 to establish a standalone PBM licensing process, require disclosure of contracts, fees and rebates to plan sponsors, and empower the superintendent of insurance to audit PBMs. Committee members asked about audit frequency and implementation; the bill received a first hearing with

Missouri limits out-of-pocket costs for insulin and epinephrine auto-injectors to $35.

Pharmacy benefit managers must prioritize low out-of-pocket cost drugs by January 2026.

PBMs must submit comprehensive drug pricing information to the commissioner starting January 2024.

New bill prohibits health plans from altering prescription drug formularies mid-plan year.

Oklahoma Attorney General can enforce penalties against pharmacy benefits managers for violations.

Board evaluates spending trends and solicits public input to lower prescription drug prices.

Senate file 315 passes to establish a competitive PBM bidding process for health plans.

Healthcare advocates push for PDAB legislation to combat high prescription drug costs in Michigan.

ALBANY, N.Y. (WNYT) – New York lawmakers from both parties are advancing proposals they say will lower costs for residents, targeting prescription drug prices, health care expenses, and utility bills ...

Senate Bill 868 aims to regulate pharmacy benefit managers to combat rising drug costs.

Legislative staff proposed amending Act 55 to raise the cap on hospital outpatient prescription drug reimbursement from 120% to 130% of average sales price; hospitals said the change could offset an estimated $6 million concern, while Blue Cross warned it could materially worsen the insurer’s financial position. The committee paused a vote to gather more numbers.

A legislative committee approved H.577 (draft 2.02), which would create a prescription drug discount card and require insurers and pharmacy benefit managers to count amounts paid via the card toward an individual’s deductible and out-of-pocket limits; the Treasurer testified that a modest uptake could save Vermonters about $18 million annually.